By Professor Kerry-Anne Rye

Journal articles

Ho JH; Liu Y; Adam S; Syed AA; Ammori BJ; Donn R; Malik R; Tabet F; Cochran BJ; Rye K-A; Soran H, 2020, 'CHANGES IN THE EFFECT OF HDL ON PANCREATIC BETA-CELL INSULIN SECRETION FOLLOWING METABOLIC SURGERY', ATHEROSCLEROSIS, 315, pp. E150 - E151, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000748958900444&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ong KL; McClelland R; Allison MA; Cushman M; Garg P; Tsai MY; Rye KA; Tabet F, 2020, 'Abstract 12911: Association of Lipoprotein (a) and Coronary Artery Calcification: Prospective Study Assessing Interactions With Other Risk Factors in the Multi-Ethnic Study of Atherosclerosis', Circulation, 142, http://dx.doi.org/10.1161/circ.142.suppl_3.12911

Weaver JC; Ullah I; Qi M; Giannakopoulos B; Rye KA; Kockx M; Kritharides L; Krilis SA, 2020, 'Free Thiol β2-GPI (β-2-Glycoprotein-I) Provides a Link Between Inflammation and Oxidative Stress in Atherosclerotic Coronary Artery Disease', Arteriosclerosis, Thrombosis, and Vascular Biology, 40, pp. 2794 - 2804, http://dx.doi.org/10.1161/ATVBAHA.120.315156

Ong KL; Wu L; Januszewski AS; O'Connell RL; Xu A; Rye KA; Ma RCW; Li H; Jenkins AJ; Jia W; Keech AC, 2020, 'Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study', Diabetes Research and Clinical Practice, 169, pp. 108450, http://dx.doi.org/10.1016/j.diabres.2020.108450

Meneses-Salas E; García-Melero A; Kanerva K; Blanco-Muñoz P; Morales-Paytuvi F; Bonjoch J; Casas J; Egert A; Beevi SS; Jose J; Llorente-Cortés V; Rye KA; Heeren J; Lu A; Pol A; Tebar F; Ikonen E; Grewal T; Enrich C; Rentero C, 2020, 'Annexin A6 modulates TBC1D15/Rab7/StARD3 axis to control endosomal cholesterol export in NPC1 cells', Cellular and Molecular Life Sciences, 77, pp. 2839 - 2857, http://dx.doi.org/10.1007/s00018-019-03330-y

Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'Opening ASBMB publications freely to all', Journal of Lipid Research, 61, pp. 969 - 970, http://dx.doi.org/10.1194/JLR.E120000903

Tabet F; Lee S; Zhu W; Levin MG; Toth CL; Cuesta Torres LF; Vinh A; Kim HA; Chu HX; Evans MA; Kuzmich ME; Drummond GR; Remaley AT; Rye KA; Sobey CG; Vickers KC, 2020, 'microRNA-367-3p regulation of GPRC5A is suppressed in ischemic stroke', Journal of Cerebral Blood Flow and Metabolism, 40, pp. 1300 - 1315, http://dx.doi.org/10.1177/0271678X19858637

Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'Opening ASBMB publications freely to all', Journal of Biological Chemistry, 295, pp. 7814 - 7815, http://dx.doi.org/10.1074/jbc.E120.014321

Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'Opening ASBMB publications freely to all', Molecular and Cellular Proteomics, 19, pp. 914 - 915, http://dx.doi.org/10.1074/mcp.E120.002125

Tucker B; McClelland RL; Allison MA; Budoff MJ; Wu BJ; Barter PJ; Rye KA; Ong KL, 2020, 'Relationship of fibroblast growth factor 21 levels with inflammation, lipoproteins and non-alcoholic fatty liver disease', Atherosclerosis, 299, pp. 38 - 44, http://dx.doi.org/10.1016/j.atherosclerosis.2020.03.009

Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'The data must be accessible to all', Journal of Biological Chemistry, 295, pp. 4371, http://dx.doi.org/10.1074/jbc.E120.013060

Ong KL; Chung RWS; Hui N; Festin K; Lundberg AK; Rye KA; Jonasson L; Kristenson M, 2020, 'Usefulness of Certain Protein Biomarkers for Prediction of Coronary Heart Disease', American Journal of Cardiology, 125, pp. 542 - 548, http://dx.doi.org/10.1016/j.amjcard.2019.11.016

Manandhar B; Cochran BJ; Rye KA, 2020, 'Role of High-Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control', Journal of the American Heart Association, 9, http://dx.doi.org/10.1161/JAHA.119.013531

Shimabukuro Okuda L; Tallada Iborra R; Ramos Pinto P; Fabres Machado U; Corrêa-Giannella ML; Pickford R; Woods T; Brimble MA; Rye KA; Passarelli M, 2020, 'Advanced Glycated apoA-IV Loses Its Ability to Prevent the LPS-Induced Reduction in Cholesterol Efflux-Related Gene Expression in Macrophages', Mediators of Inflammation, 2020, http://dx.doi.org/10.1155/2020/6515401

Nazir S; Jankowski V; Bender G; Zewinger S; Rye KA; van der Vorst EPC, 2020, 'Interaction between high-density lipoproteins and inflammation: Function matters more than concentration!', Advanced Drug Delivery Reviews, 159, pp. 94 - 119, http://dx.doi.org/10.1016/j.addr.2020.10.006

Gogonea V; Peters J; Gerstenecker GS; Topbas C; Hou L; Combet J; Didonato JA; Smith JD; Rye KA; Hazen SL, 2020, 'Protein backbone and average particle dynamics in reconstituted discoidal and spherical HDL probed by hydrogen deuterium exchange and elastic incoherent neutron scattering', Biomolecules, 10, http://dx.doi.org/10.3390/biom10010121

Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2020, 'The data must be accessible to all', Molecular and Cellular Proteomics, 19, pp. 569 - 570, http://dx.doi.org/10.1074/mcp.E120.001985

Rye KA; Davidson NO; Burlingame AL; Guengerich FP, 2020, 'Working toward reducing bias in peer review', Molecular and Cellular Proteomics, 20, http://dx.doi.org/10.1016/j.mcpro.2021.100152

Tucker B; Vaidya K; Kurup R; Khandkar C; Pandzic E; Barraclough J; Misra A; Kavurma M; Martinez G; Rye K; Cochran B; Patel S, 2020, '461 Colchicine Inhibits Neutrophil Extracellular Trap Formation in Acute Coronary Syndrome Patients Post Percutaneous Coronary Intervention', Heart, Lung and Circulation, 29, pp. S244 - S244, http://dx.doi.org/10.1016/j.hlc.2020.09.468

Stanton K; Kienzle V; Dinnes D; Jessup W; Kritharides L; Rye K; Celermajer D, 2020, '739 Moderate and High Intensity Exercise Improve Cholesterol Efflux Capacity, Lipoprotein Profile and Increase HDL Particle Size in Healthy Young Men', Heart, Lung and Circulation, 29, pp. S368 - S369, http://dx.doi.org/10.1016/j.hlc.2020.09.746

Tucker B; Vaidya K; Kurup R; Khandkar C; Barraclough J; Misra A; Kavurma M; Martinez G; Rye K-A; Cochran B; Patel S, 2020, 'COLCHICINE INHIBITS NEUTROPHIL EXTRACELLULAR TRAP FORMATION IN ACUTE CORONARY SYNDROME PATIENTS POST PERCUTANEOUS CORONARY INTERVENTION', Journal of the American College of Cardiology, 75, pp. 1346 - 1346, http://dx.doi.org/10.1016/s0735-1097(20)31973-2

Tucker B; Li H; Long X; Rye KA; Ong KL, 2019, 'Fibroblast growth factor 21 in non-alcoholic fatty liver disease', Metabolism: Clinical and Experimental, 101, http://dx.doi.org/10.1016/j.metabol.2019.153994

Wu BJ; Li Y; Ong KL; Sun Y; Johns D; Barter PJ; Rye KA, 2019, 'The Cholesteryl Ester Transfer Protein Inhibitor, des-Fluoro-Anacetrapib, Prevents Vein Bypass-induced Neointimal Hyperplasia in New Zealand White Rabbits', Scientific Reports, 9, pp. 16183, http://dx.doi.org/10.1038/s41598-019-52510-0

Magdas A; Ding J; McClelland RL; Allison MA; Barter PJ; Rye KA; Ong KL, 2019, 'The relationship of circulating fibroblast growth factor 21 levels with pericardial fat: The Multi-Ethnic Study of Atherosclerosis', Scientific Reports, 9, pp. 16423, http://dx.doi.org/10.1038/s41598-019-52933-9

Lai YC; Woollard KJ; McClelland RL; Allison MA; Rye KA; Ong KL; Cochran BJ, 2019, 'The association of plasma lipids with white blood cell counts: Results from the Multi-Ethnic Study of Atherosclerosis', Journal of Clinical Lipidology, 13, pp. 812 - 820, http://dx.doi.org/10.1016/j.jacl.2019.07.003

Ong KL; Campbell S; Wu BJ; McClelland RL; Kokkinos J; Szklo M; Polak JF; Allison MA; Rye KA, 2019, 'Relationship of fibroblast growth factor 21 with subclinical atherosclerosis and cardiovascular events: Multi-Ethnic Study of Atherosclerosis', Atherosclerosis, 287, pp. 46 - 53, http://dx.doi.org/10.1016/j.atherosclerosis.2019.06.898

Hou L; Tang S; Wu BJ; Ong KL; Westerterp M; Barter PJ; Cochran BJ; Tabet F; Rye KA, 2019, 'Apolipoprotein A-l improves pancreatic β-cell function independent of the ATP-binding cassette transporters ABCA1 and ABCG1', FASEB Journal, 33, pp. 8479 - 8489, http://dx.doi.org/10.1096/fj.201802512RR

Cuesta Torres LF; Zhu W; Öhrling G; Larsson R; Patel M; Wiese CB; Rye KA; Vickers KC; Tabet F, 2019, 'High-density lipoproteins induce miR-223–3p biogenesis and export from myeloid cells: Role of scavenger receptor BI-mediated lipid transfer', Atherosclerosis, 286, pp. 20 - 29, http://dx.doi.org/10.1016/j.atherosclerosis.2019.04.227

Wu BJ; Sun Y; Ong KL; Li Y; Tang S; Barter PJ; Rye KA, 2019, 'Apolipoprotein A-I Protects Against Pregnancy-Induced Insulin Resistance in Rats', Arteriosclerosis, Thrombosis, and Vascular Biology, 39, pp. 1160 - 1171, http://dx.doi.org/10.1161/ATVBAHA.118.312282

Kopecky C; Lytvyn Y; Domenig O; Antlanger M; Kovarik JJ; Kaltenecker CC; Poglitsch M; Perkins BA; Rye KA; Cherney DZI; Säemann MD, 2019, 'Molecular regulation of the renin–angiotensin system by sodium–glucose cotransporter 2 inhibition in type 1 diabetes mellitus', Diabetologia, 62, pp. 1090 - 1093, http://dx.doi.org/10.1007/s00125-019-4871-8

Anuwatmatee S; Allison MA; Shlipak MG; McClelland RL; Kramer H; Tang S; Hou L; Rye KA; Ong KL, 2019, 'Relationship of fibroblast growth factor 21 with kidney function and albuminuria: Multi-ethnic study of atherosclerosis', Nephrology Dialysis Transplantation, 34, pp. 1009 - 1016, http://dx.doi.org/10.1093/ndt/gfy120

Hackett MJ; Hollings A; Majimbi M; Brook E; Cochran B; Giles C; Lam V; Nesbit M; Rye KA; Mamo JCL; Takechi R, 2019, 'Multimodal Imaging Analyses of Brain Hippocampal Formation Reveal Reduced Cu and Lipid Content and Increased Lactate Content in Non-Insulin-Dependent Diabetic Mice', ACS Chemical Neuroscience, 10, pp. 2533 - 2540, http://dx.doi.org/10.1021/acschemneuro.9b00039

Kopecky C; Pandzic E; Parmar A; Szajer J; Lee V; Dupuy A; Arthur A; Fok S; Whan R; Ryder WJ; Rye KA; Cochran BJ, 2019, 'Translocator protein localises to CD11b ⁺ macrophages in atherosclerosis', Atherosclerosis, 284, pp. 153 - 159, http://dx.doi.org/10.1016/j.atherosclerosis.2019.03.011

Ong KL; Hui N; Januszewski AS; Kaakoush NO; Xu A; Fayyad R; DeMicco DA; Jenkins AJ; Keech AC; Waters DD; Barter PJ; Rye KA, 2019, 'High plasma FGF21 levels predicts major cardiovascular events in patients treated with atorvastatin (from the Treating to New Targets [TNT] Study)', Metabolism: Clinical and Experimental, 93, pp. 93 - 99, http://dx.doi.org/10.1016/j.metabol.2018.11.006

Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2019, 'For the sake of science', Molecular and Cellular Proteomics, 18, pp. 406 - 407, http://dx.doi.org/10.1074/mcp.E119.001384

Gierasch LM; Burlingame AL; Davidson NO; Rye KA, 2019, 'For the sake of science', Journal of Biological Chemistry, 294, pp. 2976, http://dx.doi.org/10.1074/jbc.E119.007916

Cochran B; Tang S; Tabet F; Cuesta Torres L; Wu B; Barter P; Rye K-A, 2019, 'Apolipoprotein A-I enhances insulin-dependent and insulinindependent glucose uptake by skeletal muscle', Scientific Reports

Ong KL; McClelland RL; Allison MA; Kokkinos J; Wu BJ; Barter PJ; Rye KA, 2019, 'Association of elevated circulating fibroblast growth factor 21 levels with prevalent and incident metabolic syndrome: The Multi-Ethnic Study of Atherosclerosis', Atherosclerosis, 281, pp. 200 - 206, http://dx.doi.org/10.1016/j.atherosclerosis.2018.10.011

Anuwatmatee S; Tang S; Wu BJ; Rye KA; Ong KL, 2019, 'Fibroblast growth factor 21 in chronic kidney disease', Clinica Chimica Acta, 489, pp. 196 - 202, http://dx.doi.org/10.1016/j.cca.2017.11.002

Rye KA; Davidson N, 2019, 'A letter from the editors-in-Chief', Journal of Lipid Research, 60, pp. 1, http://dx.doi.org/10.1194/jlr.E091447

Hui N; Barter PJ; Ong KL; Rye KA, 2019, 'Altered HDL metabolism in metabolic disorders: Insights into the therapeutic potential of HDL', Clinical Science, 133, pp. 2221 - 2235, http://dx.doi.org/10.1042/CS20190873

Gierasch LM; Davidson NO; Rye KA; Burlingame AL, 2019, 'For the sake of science', Journal of Lipid Research, 60, pp. 719 - 720, http://dx.doi.org/10.1194/jlr.E093245

Yuan D; Wu BJ; Henry A; Rye KA; Ong KL, 2019, 'Role of fibroblast growth factor 21 in gestational diabetes mellitus: A mini-review', Clinical Endocrinology, 90, pp. 47 - 55, http://dx.doi.org/10.1111/cen.13881

Kim WS; He Y; Phan K; Ahmed RM; Rye KA; Piguet O; Hodges JR; Halliday GM, 2018, 'Altered high density lipoprotein composition in behavioral variant frontotemporal dementia', Frontiers in Neuroscience, 12, http://dx.doi.org/10.3389/fnins.2018.00847

Barter PJ; Cochran BJ; Rye KA, 2018, 'CETP inhibition, statins and diabetes', Atherosclerosis, 278, pp. 143 - 146, http://dx.doi.org/10.1016/j.atherosclerosis.2018.09.033

Robinson JG; Williams KJ; Gidding S; Boršen J; Tabas I; Fisher EA; Packard C; Pencina M; Fayad ZA; Mani V; Rye KA; Nordestgaard BG; Tybjærg-Hansen A; Douglas PS; Nicholls SJ; Pagidipati N; Sniderman A, 2018, 'Eradicating the burden of atherosclerotic cardiovascular disease by lowering apolipoprotein b lipoproteins earlier in life', Journal of the American Heart Association, 7, http://dx.doi.org/10.1161/JAHA.118.009778

Wewege MA; Thom JM; Rye KA; Parmenter BJ, 2018, 'Aerobic, resistance or combined training: A systematic review and meta-analysis of exercise to reduce cardiovascular risk in adults with metabolic syndrome', Atherosclerosis, 274, pp. 162 - 171, http://dx.doi.org/10.1016/j.atherosclerosis.2018.05.002

Barter PJ; Rye KA, 2018, 'Cholesteryl Ester Transfer Protein Inhibitors as Agents to Reduce Coronary Heart Disease Risk', Cardiology Clinics, 36, pp. 299 - 310, http://dx.doi.org/10.1016/j.ccl.2017.12.011

Cochran BJ; Pinheiro D; Prendecki M; Jones B; Cegla J; Lee V; Barter PJ; Murphy AJ; Rye K-A; Woollard KJ, 2018, 'Pro-atherosclerotic Low-density Neutrophils Are Present in Hypercholesterolemia', ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 38, http://dx.doi.org/10.1161/atvb.38.suppl_1.609

Ong KL; Morris MJ; McClelland RL; Hughes TM; Maniam J; Fitzpatrick AL; Martin SS; Luchsinger JA; Rapp SR; Hayden KM; Sandfort V; Allison MA; Rye KA, 2018, 'Relationship of Lipids and Lipid-Lowering Medications with Cognitive Function', American Journal of Epidemiology, 187, pp. 767 - 776, http://dx.doi.org/10.1093/aje/kwx329

Back to profile page